Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
-
Plains All American Reports First-Quarter 2026 Results & Raises 2026 Guidance
-
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
-
Avicanna Announces Results of Annual General and Special Meeting
-
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastas
-
Indigenous Climate Resilience Network Lists Free UNEP-Recognized Drinking Water Infrastructure Planning Tool
-
Exodus Launches XO Cash as the First Stablecoin Built for AI Agents
-
iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
-
Treace Medical Concepts Reports First Quarter 2026 Financial Results
-
BsStrategy Officially Launches AI Quantitative Trading Bot to Streamline Automated Market Execution
-
Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery
-
Aben Gold Corp. Announces 2026 Exploration Program at Justin Gold Tungsten Project, Yukon
-
GigaCloud Technology Inc to Participate in 21st Annual Needham Technology, Media, & Consumer Conference
-
TeraWulf Reports First Quarter 2026 Results
-
Aegon announces final results of tender offers for five series of subordinated notes in EUR 380 million notional
-
Results of the initial public offering of Liven AS shares
-
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
-
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
-
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
-
Ultralife Corporation Reports First Quarter Results
-
illumin Reports First Quarter 2026 Financial Results
-
GigaCloud Technology Inc to Participate in 21st Annual Needham Technology, Media, & Consumer Conference
-
AMC Global Media Inc. Reports First Quarter 2026 Results
-
MapLight Therapeutics to Participate in Upcoming Investor Conferences
-
Hyperion DeFi Announces Closing of Public Offering of Common Stock
-
Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
-
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
-
BC Transit partners with Alexander Dennis for fleet upgrade with order of 41 new Enviro500 Double-Deckers
-
First Advantage to Participate in Upcoming Investor Conferences
-
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid
-
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition
-
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
-
Form 8.3 Picton Property Income Limited
-
Form 8.3 LondonMetric Property Plc & Schroder REIT Limited
-
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Form 8.3 Bluefield Solar Income Fund Ltd.
-
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
-
Form 8.3 Advanced Medical Solutions Group
-
Brookfield Business Corporation Reports Strong First Quarter 2026 Results
-
Brookfield Asset Management Announces Strong First Quarter Results
-
Castellum Announces First Quarter 2026 Financial Results
-
Kvika banki hf.: Shareholders’ Meeting Announcement
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - JTC Plc
-
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Essent Group Ltd. Announces First Quarter 2026 Results and Declares Quarterly Dividend
-
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
-
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
-
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
-
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

